Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00238082 · ClinicalTrials.gov registry record · NA
The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease
A NA study, sponsored by National Jewish Health.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00238082: Clinical Trial NA study, sponsored by National Jewish Health.
NCT00238082 is a NA study that was terminated before completion, run by National Jewish Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00238082, a NA study, was terminated before completion, sponsored by National Jewish Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an investigator-sponsored research study to evaluate if treatment with HFA-134a beclomethasone (QVAR) has an effect on peripheral (or outer) airway inflammation and airway "remodeling" or scarring in subjects with COPD. Approximately 20 subjects with COPD will participate for approximately 7 weeks, with 10 receiving an active (BDP) inhaler with HFA-134a and 10 receiving a placebo.
Interventions
- DRUG HFA-134A Beclomethasone DIpropionate (QVAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1999-11 |
| Est. Completion | 2005-02 |
| Phase | NA |
Why NCT00238082 stopped before completion
NCT00238082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which HFA-134A Beclomethasone DIpropionate (QVAR) is the first listed.
NCT00238082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00238082 about?
NCT00238082 is a clinical study titled "The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease". This is an investigator-sponsored research study to evaluate if treatment with HFA-134a beclomethasone (QVAR) has an effect on peripheral (or outer) airway inflammation and airway "remodeling" or scarring in subjects with COPD. Approximately 20 subjects with COPD will participate for approximately 7...
What is the current status of trial NCT00238082?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 1999-11. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00238082?
The interventions under investigation include: HFA-134A Beclomethasone DIpropionate (QVAR) (DRUG).
Who is sponsoring clinical trial NCT00238082?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00238082's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia